Entrada Therapeutics Inc. (TRDA)
undefined
undefined%
At close: undefined
17.66
-0.11%
After-hours Dec 13, 2024, 04:00 PM EST

Income Statement (Annual)

Get detailed income statement breakdowns, uncovering revenue, expenses, and much more.
Year FY23 FY22 FY21 FY20 FY19
Revenue 129.01M - - - -
Cost of Revenue 99.88M 1.90M 1.12M 326.00K 104.00K
Gross Profit 29.13M -1.90M -1.12M -326.00K -104.00K
Operating Income -3.16M -97.25M -51.13M -26.67M -11.82M
Interest Income 15.22M 2.63M - 144.00K 451.00K
Pretax Income 12.06M -94.62M -51.16M -26.52M -5.10M
Net Income -6.68M -87.46M -50.07M -26.38M -4.65M
Selling & General & Admin 32.29M 30.64M 15.20M 5.57M 3.61M
Research & Development 99.88M 66.61M 35.93M 21.10M 8.22M
Other Expenses - - - - 6.27M
Operating Expenses 132.18M 97.25M 51.13M 26.67M 11.82M
Interest Expense - 2.63M - - -
Selling & Marketing Expenses -1 - - - -
Cost & Expenses 132.18M 97.25M 51.13M 26.67M 11.82M
Income Tax 18.74M -7.16M -1.09M -144.00K -451.00K
Shares Outstanding (Basic) 33.05M 31.29M 31.22M 31.25M 31.25M
Shares Outstanding (Diluted) 33.05M 31.29M 31.22M 31.25M 31.25M
EPS (Basic) -0.2 -2.79 -1.6 -0.84 -0.15
EPS (Diluted) -0.2 -2.79 -1.6 -0.84 -0.15
EBITDA -321.00K -95.35M -50.01M -26.34M -11.72M
Depreciation & Amortization 2.84M 1.90M 1.12M 326.00K 104.00K